ICD10BillableValid for clinical use
ICD-10 Code I69.30: Unspecified sequelae of cerebral infarction
Reviewed by HealthAssure Clinical TeamUpdated 26 May 2026
What is this code?
ICD-10 codes are diagnosis classification codes used in healthcare records, reporting, coding workflows, and billing support. This code sits within the broader ICD-10 area for Diseases of the circulatory system (I00-I99).
đź“‹Clinical overview
This ICD-10 code is commonly used when documentation describes chronic neurologic deficits following cerebral infarction. The most accurate code depends on whether the record identifies cognitive, speech, swallowing, motor, or other residual deficits, and whether laterality or side-dominance detail is documented.
When is it used?
- May be used when a clinician documents unspecified sequelae of cerebral infarction in a patient's medical record.
- May appear in hospital records, claims, referrals, and clinical documentation.
- This code can be used as a clinically usable diagnosis entry in standardized coding workflows.
What it does not mean
- A code alone does not explain severity, treatment plan, or outcome.
- A medical code should not be treated as a substitute for a doctor's diagnosis or advice.
đź©şClinical context
When commonly used
- Neurology, stroke follow-up, rehabilitation, therapy, home-health, and primary-care documentation where lasting deficits after ischemic stroke remain clinically relevant.
- Coding and utilization-review workflows where the chart clearly links chronic neurologic impairment to prior cerebral infarction and the exact residual deficit pattern changes the final diagnosis code.
Common management context
- Post-stroke sequelae follow-up often includes neurologic exam findings, swallowing or speech assessment, cognitive review, therapy planning, mobility evaluation, and coordination across neurology, rehabilitation, and primary care.
- Documentation usually becomes more specific when the chart identifies the dominant residual deficit, affected side, dominant versus non-dominant involvement, dysphagia, aphasia, or other lasting functional impairment.
- Specialist context already linked on this page includes Cardiologist, General Physician, Neurologist, Stroke Specialist.
🔍Key distinctions
Important notes
- This ICD-10 family captures chronic sequelae attributed to prior cerebral infarction rather than an active new stroke event, and the final code usually depends on the documented residual deficit pattern.
- Cognitive, speech, swallowing, and motor deficits after ischemic stroke are coded separately from one another when the chart names the lasting impairment more specifically.
- This title reflects a broad residual-deficit code after cerebral infarction; if the chart clearly names the lasting neurologic deficit, a more specific sequela code may be used.
- Documentation that ties the residual deficit to prior cerebral infarction is coded differently from similar sequelae linked to hemorrhagic stroke or other intracranial hemorrhage.
Related codes to consider
I69.31Cognitive deficits following cerebral infarction
Related cerebrovascular-sequela ICD-10 code; documentation often becomes more specific when the chart identifies the prior stroke type, dominant residual deficit, laterality or dominance, swallowing or speech involvement, or another lasting neurologic impairment.
I69.32Speech and language deficits following cerebral infarction
Related cerebrovascular-sequela ICD-10 code; documentation often becomes more specific when the chart identifies the prior stroke type, dominant residual deficit, laterality or dominance, swallowing or speech involvement, or another lasting neurologic impairment.
I69.33Monoplegia of upper limb following cerebral infarction
Related cerebrovascular-sequela ICD-10 code; documentation often becomes more specific when the chart identifies the prior stroke type, dominant residual deficit, laterality or dominance, swallowing or speech involvement, or another lasting neurologic impairment.
I69.34Monoplegia of lower limb following cerebral infarction
Related cerebrovascular-sequela ICD-10 code; documentation often becomes more specific when the chart identifies the prior stroke type, dominant residual deficit, laterality or dominance, swallowing or speech involvement, or another lasting neurologic impairment.
Code hierarchy
chapter
9Diseases of the circulatory system (I00-I99)
block
I60-I69Cerebrovascular diseases
category
I69Sequelae of cerebrovascular disease
category
I69.3Sequelae of cerebral infarction
currentI69.3
Where you may see this code
You may see this code in hospital records, discharge summaries, insurance claims, encounter documentation, referrals, or other healthcare billing and coding records.
Related specialists
CardiologistGeneral PhysicianNeurologistStroke Specialist
Related codes
I69.31Cognitive deficits following cerebral infarctioncategoryI69.32Speech and language deficits following cerebral infarctioncategoryI69.33Monoplegia of upper limb following cerebral infarctioncategoryI69.34Monoplegia of lower limb following cerebral infarctioncategoryI69.35Hemiplegia and hemiparesis following cerebral infarctioncategoryI69.36Other paralytic syndrome following cerebral infarctioncategoryI69.39Other sequelae of cerebral infarctioncategory
Sibling codes
I69.31Cognitive deficits following cerebral infarctionI69.32Speech and language deficits following cerebral infarctionI69.33Monoplegia of upper limb following cerebral infarctionI69.34Monoplegia of lower limb following cerebral infarctionI69.35Hemiplegia and hemiparesis following cerebral infarctionI69.36Other paralytic syndrome following cerebral infarctionI69.39Other sequelae of cerebral infarction
Coverage-related procedures and services
CPT 81225high
CYP2C19 (CYTOCHROME P450, FAMILY 2, SUBFAMILY C, POLYPEPTIDE 19) (EG, DRUG METABOLISM), GENE ANALYSIS, COMMON VARIANTS (EG, *2, *3, *4, *8, *17)
Source: CMS coverage guidance
CPT 81418high
DRUG METABOLISM (EG, PHARMACOGENOMICS) GENOMIC SEQUENCE ANALYSIS PANEL, MUST INCLUDE TESTING OF AT LEAST 6 GENES, INCLUDING CYP2C19, CYP2D6, AND CYP2D6 DUPLICATION/DELETION ANALYSIS
Source: CMS coverage guidance
CPT 0349Uhigh
DRUG METABOLISM OR PROCESSING (MULTIPLE CONDITIONS), WHOLE BLOOD OR BUCCAL SPECIMEN, DNA ANALYSIS, 27 GENE REPORT, WITH VARIANT ANALYSIS, INCLUDING REPORTED PHENOTYPES AND IMPACTED GENE-DRUG INTERACTIONS
Source: CMS coverage guidance
CPT 0423Uhigh
PSYCHIATRY (EG, DEPRESSION, ANXIETY), GENOMIC ANALYSIS PANEL, INCLUDING VARIANT ANALYSIS OF 26 GENES, BUCCAL SWAB, REPORT INCLUDING METABOLIZER STATUS AND RISK OF DRUG TOXICITY BY CONDITION
Source: CMS coverage guidance
CPT 96105high
ASSESSMENT OF APHASIA (INCLUDES ASSESSMENT OF EXPRESSIVE AND RECEPTIVE SPEECH AND LANGUAGE FUNCTION, LANGUAGE COMPREHENSION, SPEECH PRODUCTION ABILITY, READING, SPELLING, WRITING, EG, BY BOSTON DIAGNOSTIC APHASIA EXAMINATION) WITH INTERPRETATION AND REPORT, PER HOUR
Source: CMS coverage guidance
CPT 72126high
COMPUTED TOMOGRAPHY, CERVICAL SPINE; WITH CONTRAST MATERIAL
Source: CMS coverage guidance
Coding guidelines
Common synonyms
Unspecified sequelae of cerebral infarction
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from ICD-10. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.